About Conference
You're invited to the "27th World Congress on Nursing, Pharmacology and Healthcare," the foremost gathering in the pharmaceutical realm, set to convene in Paris, France, from August 06-07, 2024. This year's central theme, "Empowering Pharmacists: Shaping the Future of Healthcare," promises insightful discussions on the pivotal role of pharmacists in advancing healthcare delivery. Our congress offers a strategic platform for pharmacists, researchers, industry professionals, and students to come together, exchange ideas, and explore innovative solutions to the challenges facing the pharmacy profession today.
Nursing Pharmacology 2024 serves as a catalyst for empowering pharmacists and driving positive change in healthcare. With a diverse array of keynote presentations, oral and poster sessions, symposia, workshops, exhibitions, and career development opportunities, this event provides a unique forum for networking, learning, and professional growth.
Why to Attend?
-
Professional Empowerment: Networking: Connect with fellow pharmacists, industry leaders, and experts, fostering collaborations and partnerships.
-
Cutting-edge Research: Stay updated on the latest advancements and research in pharmaceutical sciences and clinical pharmacy.
-
Career Development: Explore career opportunities, expand your skill set, and stay ahead in a rapidly evolving healthcare landscape.
-
Advocacy: Join discussions on policy issues, advocacy efforts, and the future role of pharmacists in healthcare delivery.
-
Inspiration: Hear success stories, share experiences, and be inspired by fellow pharmacists making a difference in patient care.
International Nursing Pharmacology 2024 will feature a comprehensive program covering various aspects of pharmacy practice, including clinical pharmacy, pharmaceutical sciences, pharmacy education, pharmacy management, and more.
Who Should Attend?
-
Pharmacists
-
Pharmacy students and educators
-
Pharmacy associations and societies
-
Pharmaceutical industry professionals
-
Healthcare policymakers and regulators
-
Researchers and scientists in pharmacy and related fields
Sessions & Tracks
In this session, discussions will revolve around innovative approaches in nursing education and their practical implications in healthcare settings. Topics may include evidence-based practice, nursing ethics, patient-centered care, and the integration of technology in nursing education and practice.
This track will delve into the latest advancements in pharmacology, including novel drug development, pharmacokinetics, pharmacodynamics, and drug interactions. Participants will explore emerging trends in pharmaceutical research and their potential impact on healthcare delivery and patient outcomes.
Addressing the complexities of healthcare policy and management, this session will examine strategies for optimizing healthcare delivery systems, improving patient access to care, and enhancing healthcare quality and safety. Discussions may encompass healthcare legislation, healthcare economics, health informatics, and healthcare leadership.
Focused on promoting patient safety and enhancing the quality of healthcare services, this track will explore initiatives aimed at reducing medical errors, preventing adverse events, and improving patient outcomes. Topics may include quality improvement methodologies, patient-centered outcomes research, and the role of healthcare professionals in ensuring safe and effective care delivery.
This session will examine best practices in managing chronic diseases and providing palliative care to patients with advanced illnesses. Discussions may cover disease prevention, symptom management, end-of-life care, and strategies for improving the quality of life for patients with chronic and terminal conditions.
Addressing the growing importance of mental health in healthcare, this track will explore the role of psychiatric nursing in assessing, diagnosing, and treating mental health disorders. Topics may include therapeutic interventions, psychiatric medications, stigma reduction, and the integration of mental health services into primary care settings.
This session will explore the integration of complementary and alternative therapies into conventional healthcare practices, with a focus on promoting holistic wellness and patient-centered care. Discussions may encompass mind-body interventions, nutritional therapies, acupuncture, and the evidence base supporting integrative approaches to health and healing.
Addressing disparities in healthcare access and outcomes, this track will examine global health challenges and strategies for promoting healthcare equity. Topics may include social determinants of health, health disparities among vulnerable populations, global health policy initiatives, and the role of nurses and healthcare professionals in advancing health equity worldwide.
This session will explore the latest technological innovations and informatics solutions transforming nursing practice and healthcare delivery. Discussions may include the use of electronic health records (EHRs), telehealth platforms, wearable devices, and artificial intelligence (AI) applications in nursing care coordination, patient monitoring, and clinical decision-making.
Focusing on preventive care and population health management, this track will examine the role of public health and community nursing in promoting health equity and addressing public health challenges. Topics may include community health assessment, health promotion strategies, disease prevention initiatives, and the impact of social determinants on population health outcomes.
This session will highlight translational research efforts bridging the gap between basic science discoveries and clinical applications in pharmacology and therapeutics. Discussions may cover preclinical drug development, translational pharmacokinetics/pharmacodynamics, biomarker identification, and personalized medicine approaches for optimizing drug efficacy and safety.
Addressing the evolving role of nurse leaders in shaping healthcare policy, practice, and education, this track will focus on leadership development and career advancement opportunities for nursing professionals. Topics may include leadership styles, mentorship programs, continuing education initiatives, and strategies for fostering a culture of innovation and excellence in nursing practice.
This session will explore the unique healthcare needs of older adults and strategies for providing comprehensive geriatric nursing care. Discussions may include geriatric assessment tools, age-friendly healthcare environments, gerontological nursing interventions, and interdisciplinary approaches to managing complex health issues in older populations.
Focused on personalized approaches to healthcare, this track will examine the role of precision medicine and pharmacogenomics in tailoring treatment strategies to individual patient characteristics, including genetic variations. Topics may include pharmacogenetic testing, precision oncology, pharmacogenomic-guided therapy, and the integration of genomic data into clinical decision support systems.
Emphasizing the importance of research in advancing nursing practice and improving patient outcomes, this session will showcase cutting-edge research studies and evidence-based practice initiatives. Topics may include research methodology, data analysis techniques, dissemination of research findings, and strategies for integrating research into clinical practice to enhance nursing care quality and effectiveness.
Market Analysis
The global nursing and pharmacology market reached $1.12 trillion in 2022, with a projected growth trajectory. Despite a slight decline in 2015, the market is expected to grow by 4.8% annually, with prescription sales, excluding generics, forecasted to exceed $1 trillion by 2022. The rise in generics sales, expected to constitute 10.2% of prescription sales, reflects the evolving landscape of healthcare delivery and cost-effective medication options.
Innovations in drug discovery technologies and products drive market growth, with an anticipated compound annual growth rate (CAGR) of 13.8% from 2012 to 2017, reaching $79 billion. Emphasis is placed on enhancing drug targeting to mitigate adverse effects, necessitating ongoing research in pharmacology.
Single-use technology, a rapidly expanding sector, generated $1.7 billion in revenue in 2014, with an expected CAGR of 11.7% through 2019, reaching nearly $3 billion. The growing prominence of generics and biologics underscores significant shifts in pharmaceutical development and market preferences. Biologics, comprising over a third of new drugs in trials or awaiting FDA approval, represent a substantial segment of the market.
Major Nursing and Pharmacology Associations Worldwide:
-
American Academy of Veterinary Pharmacology and Therapeutics
-
American Board of Clinical Pharmacology
-
Argentine Society for Experimental Pharmacology
-
Association of Pharmacologists of Ukraine
-
Australian Physiological and Pharmacological Society
-
British Association for Psychopharmacology
-
Colombian Association of Pharmacology
Market Overview:
Efforts in pharmacology aim to minimize serious adverse effects associated with medications, with regulations mandating comprehensive reporting of patient outcomes. Advancements in drug targeting and pharmacological research are instrumental in addressing these challenges and improving patient care globally.